Disclaimer: You are now leaving www.beiresources.org and are going to a website that is not operated by BEI Resources. We are not responsible for the content or availability of linked sites.
ABOUT THIRD PARTY LINKS ON OUR SITE: BEI Resources offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links, you will leave the BEI Resources website and will be redirected to another site. These sites are not under the control of BEI Resources. BEI Resources is not responsible for the content of linked third party websites. We are neither an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information. Please read third party privacy and security policies closely as these may be different than BEI Resources policies. If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly.
Are you sure you would like to be notified when the item is available?
Antibody class: IgG1λ ARP-1510 is a recombinant anti-HIV-1 V3 monoclonal antibody that reacts with the epitope KRIHI of the V3 loop of human immunodeficiency virus type 1 (HIV-1) MN envelope glycoprotein (gp120). ARP-1510 cross-reacts with the V3 loop peptide (20-mer) of HIV-1 SF-2, NY5, and RF. Please see the Los Alamos database for more information. Note: The user should determine the optimal concentration for any application. Each vial of ARP-1510 contains approximately 500 μg of purified antibody in phosphate-buffered saline (PBS) at a concentration of 1 mg/mL. Endotoxin content is 0.3 EU/mg. The purity is >95% as determined by SDS-PAGE. Please refer to the attached file(s) for additional information. Note: Avoid freeze-thaw cycles as reagent degradation may result.
Please include references cited below in publications.
Gorny, M. K., et al. "Repertoire of Neutralizing Human Monoclonal Antibodies Specific for the V3 Domain of HIV-1 gp120." J. Immunol. 150 (1993): 635-643. PubMed: 7678279
Gorny, M. K., et al. “Production of Site-Selected Neutralizing Human Monoclonal Antibodies against the Third Variable Domain of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein.” Proc. Natl. Acad. Sci. USA 88 (1991): 3238-3242. PubMed: 2014246
When applying for permits and forms please:
Do NOT reference BEI Resources or ATCC Catalog Numbers in the Material Description fields found on the permits and/or forms.
Make sure your name and address on the permit applications and/or forms are exactly as they appear on your BEI Resources registration.
Information about permits is provided as a courtesy to BEI Resources customers. While we use reasonable efforts to include accurate and up-to-date information on this page, we make no warranties or representation as to its accuracy.
For more information on the necessary compliance requirements associated with the biological materials provided by BEI Resources, please select this link: Compliance Requirements.